Dasatinib Intermediates
Shijiazhuang Dingmin Pharmaceutical Sciences Co., Ltd has built strategic partnerships with leading Chinese manufacturers over the last 20 years and is thus able to supply high-quality products, at a competitive price, and deliver on-time. Thanks to our extensive networking and a professional and dedicated sourcing team, we are able to provide alternative solutions to your current supply base.
Dasatinib intermediates offer to our clients a variety of advantages including superior function ability and longer life standards. Besides our standard range, we also have the expertise to produce customized variants of our range as per the specific requirements of our clients.
Dasatinib is an orally potent inhibitor of oncogenic kinases that block the signal of accelerated cancer cell replication. In May 2009, the US Food and Drug Administration (FDA) formally approved the sale of dasatinib. It has been used for the treatment of chronic myelocytic leukemia (CML), chronic or non-resistant chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, and treatment regimens including imatinib mesylate.
1. New Molecules R&D
2. API and Intermediates from China reputed manufacturers
3.Correct delivery time promise.
4.Stable quality, high quality satisfy customer's high grade sourcing request.
5.Competitive price .
We also supply other products,include 5-Fluoro-1,3-dihydro-2H-indol-2-one,Nilotinib intermediates.If you need,contact us.
